Ginkgo Bioworks, Inc. — Form D
Ginkgo Bioworks, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-23. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Other.
Offering
- Filed: 2015-07-23
- Form: D
- Accession: 0001140361-15-028340
- Industry: Other
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 68
- Date of first sale: 2015-07-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-244293
Issuer
- Name: Ginkgo Bioworks, Inc.
- CIK: 0001648827
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
- Phone: 877-422-5362
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Jason Kelly | Director | Boston, MA |
| Jason Kelly | Executive Officer | Boston, MA |
| Peter Boynton | Director | Boston, MA |
| Reshma Shetty | Director | Boston, MA |
| Reshma Shetty | Executive Officer | Boston, MA |
| Bartholomew Canton | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More